Physiological Finding in Management of COVID 19 Patients
ConditionCOVID-19 (Coronavirus Disease 2019)
Trial statusRecruiting
Trial phaseNot listed
Trial typeObservational
Biological sexAll
AgeNot listed
SponsorSt. Martin De Porress Hospital
About this trial
This study utilizes physiological indicators of COVID-19 patients as tools for assessing, tracking, worsening, and improving the clinical symptoms of COVID-19 patients. This study employs simple and easy-to-use assessment methods, which can be further aided by artificial intelligence technology to facilitate early response and medication.
Eligibility criteria
Qualifiers
Reviewing the patient's medical history, the primary focus was on hospital records and existing physiological parameters such as blood pressure, heart rate, respiratory rate, and level of consciousness. The patient received treatment at the hospital between May 2022 and March 2027
Disqualifiers
Excluding patients with incomplete clinical data or missing information in their medical records.
Trial design
Treatments tested in this trial
- physiological parameters
Treatment groups
15,000 Participants
are divided into 1 treatment groupSponsors and collaborators
Source ClinicalTrials.gov